Drug Standards of China 2025;26(1):028-033

doi:10.19778/j.chp.2025.01.005

Overview of Chinese Pharmacopoeia 2025 Edition Volume Ⅲ

CAO Yan ; ZHAO Xiong ; WANG Xiaojuan ; CHEN Huiyi ; LI Huiyi

Keywords

Chinese Pharmacopoeia; drug standard; new admission and revision

Country

China

Language

Chinese

Abstract

“Chinese Pharmacopoeia” is the legal basis for drug development, production, operation, use and management in China, and the Chinese Pharmacopoeia 2025 Edition is going to be issued and implemented. This article introduces the revision and amendment situations, analyzes the characteristics of the new edition of the Pharmacopoeia and the future development direction of national standards for better understanding and implementation of the latest edition of pharmacopoeia.